scispace - formally typeset
M

Michael Allerhand

Researcher at University of Edinburgh

Publications -  64
Citations -  3343

Michael Allerhand is an academic researcher from University of Edinburgh. The author has contributed to research in topics: Cognition & Cognitive decline. The author has an hindex of 25, co-authored 64 publications receiving 2799 citations. Previous affiliations of Michael Allerhand include University of Cambridge.

Papers
More filters
Journal ArticleDOI

Time‐domain modeling of peripheral auditory processing: A modular architecture and a software platform

TL;DR: A software package with a modular architecture has been developed to support perceptual modeling of the fine-grain spectro-temporal information observed in the auditory nerve, including new forms of periodicity-sensitive temporal integration that generate stabilized auditory images.
Book ChapterDOI

Complex Sounds and Auditory Images

TL;DR: In this article, the authors review the perception of four types of complex sound, two traditional (pulse trains and vowels), and two novel (Profile Analysis, PA, and Comodulation Masking Release, CMR).
Journal ArticleDOI

Cognitive Test Scores in UK Biobank: Data Reduction in 480,416 Participants and Longitudinal Stability in 20,346 Participants.

TL;DR: Cognitive data from UK Biobank has the potential to be a significant resource for researchers looking to investigate predictors and modifiers of cognitive abilities and associated health outcomes in the general population.
Journal ArticleDOI

Vascular risk factors, large-artery atheroma, and brain white matter hyperintensities

TL;DR: The small effect of VRFs and LAD on WMH suggests that WMH have a large “nonvascular,” nonatheromatous etiology, and VRF modification, although important, may be limited in preventing WMH and their stroke and dementia consequences.
Journal ArticleDOI

Cognitive function trajectories and their determinants in older people: 8 years of follow-up in the English Longitudinal Study of Ageing

TL;DR: The potential determinants of cognitive decline identified in this study, in particular modifiable risk factors, should be tested in the context of randomised controlled trials.